Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion

Jefferies Financial Group's Rating of Life Science REIT on 3/27/2023

On March 27, 2023, Jefferies Financial Group updated its outlook on Life Science REIT (LON:LABS) with the action "Reiterated Rating", keeping a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Jefferies Financial Group Inc.

DateCompanyAction
10/23/2026
DTE Energy Company stock logo
DTE
DTE Energy
Set Price Target
10/23/2026
LKQ Corporation stock logo
LKQ
LKQ
Reiterated Rating
10/23/2026
Bloom Energy Corporation stock logo
BE
Bloom Energy
Reiterated Rating
10/23/2026
Zymeworks Inc. stock logo
ZYME
Zymeworks
Reiterated Rating
10/23/2026
First Citizens BancShares, Inc. stock logo
FCNCA
First Citizens BancShares
Reiterated Rating
10/23/2026
Skydance Corporation stock logo
SKYD
Skydance
Upgrade
More Ratings From Jefferies Financial Group Inc.